WuXi PharmaTech Attends the IBC's 11th Annual World Congress
Aug 22, 2006
August 22, Shanghai, China – WuXi PharmaTech recently attended the IBC's 11th Annual World Congress of Drug Discovery Technology ® & Development in Boston, Massachusetts. The conference was held at the Seaport World Trade Center and Hotel, where over 200 industry leading speakers presented to six dedicated conference programs.
The IBC Congress is the world's largest gathering of drug discovery researchers, scientists, and executives. With more than 280 Biotechnology companies, Boston is an ideal venue for the gathering.
With a 30'x10' booth and five staff members led by Dr. Shuhui Chen, the Chief Scientific Officer, WuXi PharmaTech as a first-time exhibitor was well received at the conference. This showcase is a great forum for WuXi PharmaTech to learn about the latest news in the drug discovery field as well as to promote the company's high-quality and value-added services to existing and potential collaboration partners.
Thus far the meeting has been a success, "Many people visited our booth and it seems that many already equate WuXi PharmaTech with high-quality chemistry services," said Dr. Shuhui Chen. Although this is WuXi PharmaTech's first attendance of the IBC drug discovery conference, WuXi PharmaTech has been providing high-quality and value-added services to support new drug discovery and chemical development for its partners since its founding in 2001.
About IBC Life Sciences
IBC Life Sciences has supported and supplied the life science industry with specialized information through its conferences and publications since 1987. Since then, they have developed a tradition of quality leaning and networking events while establishing industry-leading events in North America and Europe in three primary market sectors: Drug Discovery, Microtechnology, and Biopharmaceutical Production.
About WuXi PharmaTech (Cayman) Inc. WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.